Advertisement

Topics

TapImmune, Inc. Company Profile

06:51 EDT 24th June 2018 | BioPortfolio

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T-cells, helper T-cells and to restore or further augment antigen presentation by using proprietary nucleic acid-based expression systems. The Company’s vaccine compositions may be used as stand-alone medications or in combination with current treatment modalities. Please visit the Company’s website at www.tapimmune.com for details.


News Articles [40 Associated News Articles listed on BioPortfolio]

TapImmune to Present at 2018 Disruptive Growth Healthcare Conference

TapImmune Company Presentation Date: Wednesday, May 9th, 2018 Time: 11:35 AM ET Location:Track 1 | Room A/B About TapImmune Inc. Read more...

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference

An audio webcast will be accessible via the News and Events section of the TapImmune website: https://tapimmune.com/events. An archive of the audio will remain Read more...

TapImmune and Marker Therapeutics Enter into Merger Agreement, Creating a Transformational Immuno-Oncology Platform

JACKSONVILLE, Florida – May 15, 2018 – TapImmune Inc. (NASDAQ: TPIV) (“TapImmune”) today announced that it has entered into a definitive merger agreement to acquire Marker Therapeutics, Inc...

M&As this week: TapImmune, CalibreScientific, Medicover Holding

US-based clinical-stage immuno-oncology company TapImmune has signed an agreement to merge with Marker Therapeutics. The merger has been unanimously approved...Read More... The post M&As this wee...

TapImmune to acquire Marker Therapeutics

US clinical-stage immuno-oncology company TapImmune has entered into a definitive merger agreement to…

TapImmune gets $3.1mm through private placement ahead of merger

Cancer immunotherapies developer TapImmune Inc. sold 3.1mm common shares priced at $2.40 (an 18% discount) to its largest shareholder Eastern Capital, for gross proceeds of $3.1mm. The private placeme...

TapImmune agrees to merge with Marker Therapeutics

US-based immunotherapies company TapImmune has signed a definitive merger agreement to buy multi-antigen T-cell therapy platform developer Marker Therapeutics. The...Read More... The post TapImmune ag...

TapImmune partnership with Big Pharma? If geography and finances are right, says CEO

TapImmune would consider a partnership deal with a major pharmaceutical firm in a non-Caucasian country, such as Japan or China, if âvery compellingâ from a financial standpoint, says CEO.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

TapImmune, Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

More Information about "TapImmune, Inc." on BioPortfolio

We have published hundreds of TapImmune, Inc. news stories on BioPortfolio along with dozens of TapImmune, Inc. Clinical Trials and PubMed Articles about TapImmune, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TapImmune, Inc. Companies in our database. You can also find out about relevant TapImmune, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record